Aligos Therapeutics Price Chart
Aligos Therapeutics Volume Chart
Aligos Therapeutics Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
+0.50(+6.69%)
| Open | $7.47 |
|---|---|
| Close | $7.97 |
| Low | $7.33 |
| Low Change | -0.15 (-1.94%) |
| High | $8.00 |
| High Change | +0.53 (+7.10%) |
| Range | $0.68 |
| Volume | 34.108K |
| Dollar Volume | $271.84K |
Premarket
+0.00(+0.00%)
| Open | $7.23 |
|---|---|
| Close | $7.23 |
| Low | $7.23 |
| Low Change | 0.00 (0.00%) |
| High | $7.23 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 252 |
| Dollar Volume | $1.82K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.14(+1.78%)
| Open | $7.59 |
|---|---|
| Close | $7.73 |
| Low | $7.55 |
| Low Change | -0.04 (-0.53%) |
| High | $7.99 |
| High Change | +0.40 (+5.27%) |
| Range | $0.44 |
| Volume | 57.026K |
| Dollar Volume | $440.53K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $7.43 |
|---|---|
| Close | $7.43 |
| Low | $7.43 |
| Low Change | 0.00 (0.00%) |
| High | $7.43 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 2.365K |
| Dollar Volume | $17.57K |
Aligos Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $7.08 |
|---|---|
| 10 Day Moving Average (SMA10) | $6.98 |
| 20 Day Moving Average (SMA20) | $7.09 |
| 50 Day Moving Average (SMA50) | $7.27 |
| 100 Day Moving Average (SMA100) | $8.28 |
| 200 Day Moving Average (SMA200) | $8.65 |
Aligos Therapeutics Statistics
| Average Volume (30 Days) | 38.15K |
|---|---|
| P/E Ratio (Current) | -1.90 |
| EPS (Current) | -$3.91 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$82.94M |
| Cash Ratio | 0.86 |
| Current Ratio | 3.90 |
| Quick Ratio | 3.90 |
| Debt to Equity | 0.00 |
| Enterprise Value | $27.86M |
| EV to EBITDA | -0.32 |
| EV to Sales | 12.75 |
| Price to Book | 0.86 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 21.03 |
| Return on Assets | -0.27% |
| Return on Equity | -0.45% |
Aligos Therapeutics Stock Splits
There has been 1 stock split for Aligos Therapeutics (ALGS). The reverse stock split occured on August 19, 2024 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Aug 19, 2024 | Reverse | 25:1 |
Aligos Therapeutics Dividends
There have been no dividends for Aligos Therapeutics (ALGS).